Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes

Diabetologia

Volumn 42, Issue 6, 1999, Pages 678-687

  Hermans, M P ^a,b   Levy, J C ^a   Morris, R J ^a   Turner, R C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

CIGMA; Discriminant ratio; HOMA; Insulin sensitivity; Insulin tolerance test; Intravenous glucose tolerance test; Reproducibility; Type II diabetes

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIET RESTRICTION; DISCRIMINANT ANALYSIS; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 0033060866     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051215     Document Type: Article

References (52)

1. 1. Ward WK, Johnston CLW, Beard JC, Benedetti TJ, Halter JB, Porte D Jr (1985) Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes 34: 861-869
2. 2. UK Prospective Diabetes Study V (1988) Characteristics of newly presenting type 2 diabetic patients: estimated insulin sensitivity and islet B-cell function. Diabet Med 5: 444-448
3. 3. DeFronzo RA (1988) The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667-687
4. 4. Erikson J, Franssila-Kallunki A, Ekstrand A et al. (1989) Early metabolic abnormalities in persons at increased risk for non-insulin-dependent diabetes mellitus. N Eng J Med 321: 337-343
5. 5. Page RCL, Walravens EKN, Levy JC, Stratton IM, Turner RC (1992) Prevalence and pathophysiology of impaired glucose tolerance in three different high-risk groups. Metabolism 42: 932-938
6. 6. Beck-Nielsen H, Groop L (1994) Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94: 1714-1721
7. 7. Zawalich WS, Kelley GG (1995) The pathogenesis of NIDDM: the role of the pancreatic beta-cell. Diabetologia 38: 986-991
8. 8. Reaven GM (1995) The fourth musketeer - from Alexandre Dumas to Claude Bernard. Diabetologia 38: 3-13
9. 9. Groop LC (1993) Insulin resistance and insulin deficiency in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36: 1326-1331
10. 10. Taylor SI, Accili D, Imai Y (1994) Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM. Diabetes 43: 735-740
11. 11. Kumar S, Boulton AJM, Beck-Nielsen H et al. for the Troglitazone study group (1996) Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Diabetologia 39: 701-709
12. 12. Henry RR (1996) Effect of troglitazone on insulin sensitivity. Diabet Med 13: S148-S150
13. 13. Bergman RN, Finegood D, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocrine Reviews 6: 45-86
14. 14. Ader M, Bergman RN (1987) Insulin sensitivity in the intact organism. In: Baillières Clin Endocrinol Metab 1: 879-910
15. 15. Bergman RN, Hope ID, Yang YJ et al. (1989) Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev 5: 411-429
16. 16. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
17. 17. Pacini G, Bergman RN (1986) MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23: 113-122
18. 18. Bergman RN, Prager R, Volund A, Olefsky JM (1987) Equivalence of the insulin sensitivity index in man derived from the Minimal Model method and the euglycemic glucose clamp. J Clin Invest 79: 790-800
19. 19. Bergman RN (1989) Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38: 1512-1527
20. 20. Saad MF, Anderson RL, Laws A et al. for the Insulin Resistance Atherosclerosis Study (1994) A comparison between the Minimal Model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43: 1114-1121
21. 21. Anderson RL, Hamman RF, Savage PJ et al. for the Insulin Resistance Atherosclerosis Study (1995) Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIVGT) tests. Am J Epidemiol 142: 724-732
22. 22. Caumo A, Giacca A, Morgese M, Pozza G, Micossi P, Cobelli C (1991) Minimal Model of glucose disappearance: lessons from the labelled IVGTT. Diabet Med 8: 822-832
23. 23. Bonora E, Moghetti P, Zancanaro C et al. (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68: 374-378
24. 24. Hosker JP, Matthews DR, Rudenski AS et al. (1985) Continuous infusion of glucose with model assessment: measurement of insulin resistance and β-cell function in man. Diabetologia 28: 401-411
25. 25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis Model Assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28: 412-419
26. 26. Levy JC, Rudenski AS, Burnett M, Knight R, Matthews DR, Turner RC (1991) Simple empirical assessment of β-cell function by a constant infusion of glucose test in normal and Type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 34: 488-499
27. 27. Rudenski AS, Matthews DR, Levy JC, Turner RC (1991) Understanding 'insulin resistance': both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 40: 908-917
28. 28. Turner RC, Levy JC, Rudenski AS, Hammersley M, Page R (1993) Measurement of insulin resistance and beta-cell function: the HOMA and CIGMA approach. In: Belfiore F, Bergman RN, Molinatti GM (eds) Current topics in diabetes research. Karger, Basel, 12: 66-75
29. 29. Riggs DS, Guarnieri JA, Addelman S (1978) Fitting straight lines when both variables are subject to error. Life Sciences 22: 1305-1360
30. 30. British Standards Institution (1979) Precision of test methods I: Guide for the determination and reproducibility for a standard test method (BS 5497, part 1), British Standards Institution, London
31. 31. Godfrey K (1985) Simple linear regression in medical research. N Eng J Med 313: 1629-1636
32. 32. Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i: 307-310
33. 33. Spilker B (1991) Validation of clinical tests and measures. In: Guide to clinical trials. Raven Press, New York, pp 313-319
34. 34. Levy JC, Morris RJ, Hammersley M, Turner RC (1999) Comparison of imprecise physiological tests: discrimination, maximum expected rank correlation and unbiased equivalence. Am J Phys (in press)
35. 35. World Health Organisation Study Group on Diabetes Mellitus (1985) Technical Report Series No 727, WHO, Geneva
36. 36. Levy JC, Matthews DR, Hermans MP (1998) Correct Homeostasis Model Assessment (HOMA) evaluation uses the computer program. Diabetes Care 21: 2191-2192
37. 37. Raggat PR (1989) Duplicates or singletons? An analysis of the need for replication in immunoassay and a computer program to calculate the distribution of outliers, error rate and the precision profile from assay duplicates. Ann Clin Biochem 26: 23-37
38. 38. Taniguchi A, Nakai Y, Fukushima M et al. (1992) Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41: 1540-1546
39. 39. Finegood DT, Hramiak IM, Dupré J (1990) A modified protocol for estimation of insulin sensitivity with the Minimal Model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 70: 1538-1549
40. 40. Ferrari P, Alleman Y, Shaw S, Riesen W, Weidmann P (1991) Reproducibility of insulin sensitivity measured by the minimal model method. Diabetologia 34: 527-530
41. 41. Avogaro A, Bristow JD, Bier DM, Cobelli C, Toffolo G (1989) Stable-label intravenous glucose tolerance test Minimal Model. Diabetes 38: 1048-1055
42. 42. Steil GM, Volund A, Kahn SE, Bergman RN (1993) Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the Minimal Model. Suitability for use in population studies. Diabetes 42: 250-256
43. 43. Duysinx BC, Scheen AJ, Gerard PL, Letiexhe MR, Paquot N, Lefebvre PJ (1994) Measurement of insulin sensitivity by the minimal model method using a simplified intravenous glucose tolerance test: validity and reproducibility. Diabetes Metab 20: 425-432
44. 44. Coates PA, Ollerton RL, Luzio SD, Ismail IS, Owens DR (1993) Reduced sampling protocols in estimation of insulin sensitivity and glucose effectiveness using the Minimal Model in NIDDM. Diabetes 42: 1635-1641
45. 45. Matthews DR, Lang DA, Burnett MA, Turner RC (1983) Control of pulsatile insulin secretion in man. Diabetologia 24: 231-237
46. 46. Galvin P, Ward G, Walters J et al. (1992) A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med 9: 921-928
47. 47. Akinmokun A, Selby PL, Ramaiya K, Alberti KGM (1992) The short insulin tolerance test for determination of insulin sensitivity: a comparison with the euglycaemic clamp. Diabet Med 9: 432-437
48. 48. Hirst S, Phillips DIW, Vines SK, Clark PM, Hales CN (1993) Reproducibility of the short insulin tolerance test. Diabet Med 10: 839-842
49. 49. Olefsky JM, Farquhar JW, Reaven G (1973) Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes 22: 507-513
50. 50. Bonora E, Manicardi V, Zavaroni I, Coscelli C, Butturini U (1987) Relationships between insulin secretion, insulin metabolism and insulin resistance in mild glucose intolerance. Diabete Metabolisme 13: 116-121
51. 51. Kahn SE, Prigeon RL, McCullogh DK et al. (1993) Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42: 1663-1672
52. 52. Haffner SM, Gonzales C, Miettinen H, Kennedy E, Stern MP (1996) A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 19: 1138-1141